New York Life Investment Management’s Qiagen QGEN Stock Holding History

New York Life Investment Management’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-22,041	Closed	-$985K	–	835
2025 Q3	$985K	Sell	22,041 -572	-3%	-$27.4K	0.01%	659
2025 Q2	$1.09M	Sell	22,613 -476	-2%	-$20.7K	0.01%	633
2025 Q1	$927K	Buy	23,089 +263	+1%	+$11.1K	0.01%	659
2024 Q4	$1.05M	Sell	22,826 -2,709	-11%	-$121K	0.01%	647
2024 Q3	$1.2M	Sell	25,535 -1,464	-5%	-$66.8K	0.01%	664
2024 Q2	$1.14M	Buy	26,999 +3,246	+14%	+$142K	0.01%	656
2024 Q1	$1.05M	Sell	23,753 -634	-3%	-$28.9K	0.01%	661
2023 Q4	$1.12M	Buy	24,387 +1,552	+7%	+$66K	0.01%	633
2023 Q3	$981K	Buy	22,835 +12,126	+113%	+$565K	0.01%	631
2023 Q2	$511K	Buy	+10,709	New	+$516K	0.01%	704

Other funds holding QGEN

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

New York Life Investment Management's QGEN Position: Q4 2025 in Review

New York Life Investment Management sold out of Qiagen (QGEN) in Q4 2025, closing a stake of 22,041 shares — an estimated $985K sold.

New York Life Investment Management first reported a position in QGEN in Q2 2023 and held it in 10 quarters. The position peaked at $1.2M in Q3 2024. 321 funds tracked by Wall St. Rank hold QGEN as of Q4 2025.

New York Life Investment Management reported no remaining Qiagen position as of Q4 2025 after selling out during the quarter.
New York Life Investment Management sold 22,041 Qiagen shares in Q4 2025, an estimated $985K.
New York Life Investment Management first reported a position in Qiagen in Q2 2023 and held it in 10 quarters.
New York Life Investment Management's Qiagen position peaked at $1.2M in Q3 2024.
321 funds tracked by Wall St. Rank held Qiagen as of Q4 2025.

Based on New York Life Investment Management's 13F filing for Q4 2025, filed 5 Feb 2026.